エピソード

  • RVMD Today - Aug 12: Fresh RAS Drug Demand

    RVMD Today - Aug 12: Fresh RAS Drug Demand
    2026/08/12
    Hey there! It’s Joey, your friendly neighborhood investor, breaking down today’s market action. Today, we’re talking about Revolution Medicines, or RVMD for short. It was a pretty chill day, up just a smidge—like 0.84%.

    So, what went down? RVMD barely moved, but there’s some buzz around it. The stock's been getting attention for its new RAS cancer drugs, which are apparently in high demand. People are definitely noticing that, and it seems like the company is sitting pretty with a market cap of around $44 billion. Not too shabby, right?

    Now, why’s everyone talking about RVMD? Well, a couple of reasons. First off, the fresh demand for those RAS drugs is sparking interest from big pharma. You know how it goes—if something's hot, everyone wants a piece of it. Plus, there’s chatter that RVMD could be a takeover target, which is always a juicy topic in the investment world. It’s like that classic game of musical chairs; everyone’s trying to figure out who’s gonna grab it next. And on top of that, Handelsbanken Fonder just upped their stake in RVMD. So, clearly, some folks think this is a solid play.

    Oh, and here’s a little nugget to keep in mind: BeOne Medicines just teamed up with Revolution Medicines to work on some oncology therapies. Collaborations like this can mean more innovation and potential breakthroughs, so that’s definitely something to watch.

    So, to wrap it all up, RVMD had a quiet day but is definitely stirring up some excitement with that fresh RAS drug demand and big pharma interest. Remember, this info is just for fun and to keep you in the loop, not financial advice. Catch ya later!
    続きを読む 一部表示
    2 分
  • RVMD Today - Aug 11: Collaboration with BeOne Medicines

    RVMD Today - Aug 11: Collaboration with BeOne Medicines
    2026/08/11
    Hey there! It’s Joey here, your friendly longtime investor, breaking down the stock action for Revolution Medicines today. So, RVMD was in the red, down about 1.25%.

    What happened? Well, the stock had a bit of a rough day. It opened strong but lost some steam as the day went on. It got smoked a bit, but honestly, it wasn’t a huge surprise given the market vibes.

    Now, let’s talk about why this happened. There’s some buzz around a new collaboration with BeOne Medicines for oncology therapies. That sounds great on paper—like a solid partnership for tackling cancer. But sometimes, these deals can bring mixed feelings. Investors might be thinking about how this affects RVMD’s valuation. Some folks are excited, but others are a bit cautious, especially with Bank of America cutting their holdings in RVMD. Yeah, that one stung for sure. It’s like when your friend tells you they’re not feeling your favorite band anymore, and you’re left wondering if you should still rock out to their tunes.

    Also, TD Cowen reiterated a “Buy” rating on the stock, which is a positive sign. But with the mixed signals from the market, it’s like a rollercoaster of emotions for investors.

    One thing worth keeping in mind is that RVMD recently hit a new 12-month high. That’s a big deal! It shows that there’s been some serious interest in the stock lately.

    So, to wrap it up, RVMD had a bit of a tough day, but there are some exciting developments happening. Just remember, this is all for fun and info. I’m not here to tell you what to do with your money. Just keep an eye on the news and do what feels right for you. Catch you later!
    続きを読む 一部表示
    2 分
  • RVMD Today - Aug 10: Stays Steady Amid News

    RVMD Today - Aug 10: Stays Steady Amid News
    2026/08/10
    Hey there! It’s Joey here, your friendly investor buddy, and I’ve been in the game for a while. Today, we're chatting about Revolution Medicines, or RVMD for short. It was kind of a chill day, barely moved, just a tiny uptick of 0.16%.

    So, what went down? Well, RVMD had a pretty steady day. It didn’t get smoked, but it didn’t exactly shoot for the stars either. Just a slow and steady vibe. The trading volume was right around the average, so nothing too wild happening there.

    Now, why did it play out this way? Some interesting stuff came to light. TD Cowen kept the stock rating at a solid Buy, which is a thumbs-up for RVMD. That probably gave some investors a little boost of confidence. Also, BeOne snagged exclusive rights to four cancer medicines in certain Asian markets. That’s a big deal, right? More markets mean more potential sales. Plus, there’s been a growing demand for Daraxonrasib, one of their treatments. People are talking about it, and it sounds like that’s been helping RVMD bounce back a bit after some rough patches.

    Oh, and get this: Assenagon Asset Management picked up over 200,000 shares of RVMD. Major institutional buying can be a good sign, showing that some big players are betting on the stock.

    Now, looking ahead, Revolution Medicines is still in the game with Daraxonrasib and its pipeline. So, there’s definitely stuff cooking.

    Alright, that’s a wrap for today! Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • RVMD Today - Aug 09: Demand Drives Price Up

    RVMD Today - Aug 09: Demand Drives Price Up
    2026/08/09
    Hey there! I’m Joey, a longtime investor, and I’m here to break down the day’s action for Revolution Medicines, or RVMD. So, today was a green day for them, up about 3.7%. Not too shabby!

    Here’s the scoop. RVMD saw some nice movement today, and honestly, it’s been a rollercoaster lately. There’s been a lot of talk about their drug, Daraxonrasib, really picking up steam. Apparently, there’s a growing demand for it, which is definitely giving the stock a boost. I mean, after some tough losses recently, it’s like the market’s finally giving them a little love.

    Now, let’s get into the why. Assenagon Asset Management jumped in and bought a hefty chunk of shares—over 200,000 of them. That’s a solid vote of confidence right there. Meanwhile, J.P. Morgan’s keeping the faith too, maintaining a buy rating and even raising their target price to $227. So, folks are clearly seeing potential here. On the flip side, Sei Investments decided to cut down their holdings, which is a bit of a mixed bag, but the overall vibe today was pretty positive.

    One thing that’s worth mentioning is that the demand for Daraxonrasib seems to be a game-changer for them. As more buzz builds around it, it could really shake things up for RVMD in the coming months.

    Alright, that’s the scoop for today! Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • RVMD Today - Aug 08: Exciting Drug Launch Buzz

    RVMD Today - Aug 08: Exciting Drug Launch Buzz
    2026/08/08
    Hey there! It’s Joey, your friendly longtime investor here, breaking down the day’s action. Today we’re talking about Revolution Medicines, RVMD for short. It had a solid green day, up about 3.7%. Not a bad way to kick things off!

    So, what happened? RVMD saw a nice bump today, and it’s all about the buzz around their pancreatic cancer drug. People are pretty hyped about it. The company’s getting ready to launch what they’re calling a potential blockbuster. That kind of talk gets investors excited, right?

    Now, why the hype? Well, there’s been some chatter about their study data for the drug, and even Martin Shkreli, you know, the controversial figure from the pharma world, stepped in to defend the data. Not everyone loves him, but when he talks about a drug, people listen. Plus, there was news about a 45% surge in another biotech related to pancreatic cancer tests, which probably got the whole sector buzzing. It’s like a wave, and RVMD is riding it!

    On the horizon, the company’s gearing up for this launch, and they’re really pumped about it. They’re saying they’re ready to go, which always sounds promising. Launching a drug like this could be a game-changer for them.

    So, to wrap it up, RVMD had a good day, fueled by excitement over their pancreatic cancer drug and some lively conversation around their study data. Always a bit of drama in biotech, right? Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • RVMD Today - Aug 06: Eye-Popping Cancer Test Results

    RVMD Today - Aug 06: Eye-Popping Cancer Test Results
    2026/08/06
    Hey there! It’s Joey here, your friendly neighborhood investor, and I’m breaking down the day for Revolution Medicines, ticker RVMD. Today was a green day, up just a bit at 0.44%.

    So, what went down? RVMD had a pretty steady day, but it didn’t blow the roof off. The stock hit an all-time high earlier in the day, which got some folks buzzing. After that, it kind of settled in, not moving much at the close.

    Now, why all the hype? Well, there’s this new pancreatic cancer test that really caught eyes. Apparently, it surged 45% on some impressive results. That’s the kind of news that gets investors excited! But then, there was also chatter about their Q2 earnings call, where they talked about widening losses due to increased R&D spending. That’s a mixed bag, for sure. People are stoked about the potential, but those losses can sting a bit.

    Another thing to keep in mind is that the biotech space is a bit wild right now. There was a huge drop in another stock related to cancer trials, which might’ve made investors a little jittery. So, RVMD’s steady climb today might be a sign of folks looking for safer bets in the biotech arena.

    One quick thing on the horizon: their research and development efforts are ramping up, so keep an eye on that. It could lead to some major breakthroughs or, you know, some more losses.

    Alright, that’s all for today! Just remember, this is all for fun and info—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • RVMD Today - Aug 05: Hits All-Time High

    RVMD Today - Aug 05: Hits All-Time High
    2026/08/05
    Hey there! It’s Joey here, your friendly investor who's been keeping an eye on the markets for years. Today, we’re talking about Revolution Medicines, or RVMD for short. It was a solid green day—up a little over half a percent, which is nice, but it actually hit an all-time high earlier in the session!

    So here’s the scoop: RVMD opened strong and even touched a high of 195.48. That’s a big deal! People were definitely feeling the hype, pushing the stock to that peak. But by the end of the day, it closed a bit lower at 194.69. Still, hitting a new high is always a good sign, right? It’s like when you finally beat your high score in a game.

    Now, why the excitement? Well, a couple of articles pointed out that RVMD is really gaining traction in the cancer drug game. There’s chatter about it potentially becoming a $20 billion story. That’s wild! Investors are clearly catching on to the potential here. But, on the flip side, there’s also some buzz about them possibly posting a loss in earnings soon. That could have some folks sweating, but for now, the momentum seems to be on their side.

    One other thing to keep an eye on: RVMD is one of those mid-cap stocks that just made a new 52-week high. That’s always a point of interest for traders looking for growth stories. It’s like finding the hidden gem in a treasure hunt!

    So, to wrap it up, RVMD had a pretty exciting day, hitting that all-time high before settling down a bit. It’s definitely a stock that’s got people talking, especially with the potential it has in the cancer treatment space. Just remember, while it's fun to watch these stocks move, this info is just for your entertainment and not financial advice. Stay savvy, and catch you later!
    続きを読む 一部表示
    2 分